Veronique Boyer-Gelsi

Marseille, France

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 34 publications

Venetoclax-based non-intensive induction followed by allogenic stem-cell transplantation in elderly acute myeloid leukemia patients with adverse cytogenetics.

Venetoclax-based non-intensive induction followed by allogenic stem-cell transplantation in elderly acute myeloid leukemia patients with adverse cytogenetics.

Journal: European journal of haematology
Published: April 03, 2024

Genetic deletion of JAM-C in preleukemic cells rewires leukemic stem cell gene expression program in AML.

Genetic deletion of JAM-C in preleukemic cells rewires leukemic stem cell gene expression program in AML.

Journal: Blood advances
Published: September 21, 2023

Azacitidine-venetoclax versus azacitidine salvage treatment for primary induction failure or first relapsed acute myeloid leukaemia patients.

Azacitidine-venetoclax versus azacitidine salvage treatment for primary induction failure or first relapsed acute myeloid leukaemia patients.

Journal: European journal of haematology
Published: August 03, 2023

Erythroleukemia: Classification.

Erythroleukemia: Classification.

Journal: EJHaem
Published: February 03, 2023

Azacitidine Plus Venetoclax for the Treatment of Relapsed and Newly Diagnosed Acute Myeloid Leukemia Patients.

Azacitidine Plus Venetoclax for the Treatment of Relapsed and Newly Diagnosed Acute Myeloid Leukemia Patients.

Journal: Cancers
Published: March 08, 2022

Gains of EPOR and ERG genes in adult erythroleukaemia.

Gains of EPOR and ERG genes in adult erythroleukaemia.

Journal: British journal of haematology
Published: April 01, 2020

Acute erythroid leukemias have a distinct molecular hierarchy from non-erythroid acute myeloid leukemias.

Acute erythroid leukemias have a distinct molecular hierarchy from non-erythroid acute myeloid leukemias.

Journal: Haematologica
Published: October 12, 2019

Human erythroleukemia genetics and transcriptomes identify master transcription factors as functional disease drivers.

Human erythroleukemia genetics and transcriptomes identify master transcription factors as functional disease drivers.

Journal: Blood
Published: August 27, 2019

Post-remission therapy of adults aged 60 and older with acute myeloid leukemia in first complete remission: role of treatment intensity on the outcome.

Post-remission therapy of adults aged 60 and older with acute myeloid leukemia in first complete remission: role of treatment intensity on the outcome.

Journal: Annals of hematology
Published: June 20, 2019

Mutation patterns in essential thrombocythemia, polycythemia vera and secondary myelofibrosis.

Mutation patterns in essential thrombocythemia, polycythemia vera and secondary myelofibrosis.

Journal: Leukemia & lymphoma
Published: January 03, 2019

Autoimmune diseases in myelodysplastic syndrome favors patients survival: A case control study and literature review.

Autoimmune diseases in myelodysplastic syndrome favors patients survival: A case control study and literature review.

Journal: Autoimmunity reviews
Published: July 07, 2018

Revisiting gene mutations and prognosis of ex-M6a-acute erythroid leukemia with regard to the new WHO classification.

Revisiting gene mutations and prognosis of ex-M6a-acute erythroid leukemia with regard to the new WHO classification.

Journal: Blood cancer journal
Published: August 26, 2017
Showing 1-12 of 34

Last Updated: 09/26/2026